Eva Salgado

1.3k total citations
22 papers, 804 citations indexed

About

Eva Salgado is a scholar working on Rheumatology, Hematology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Eva Salgado has authored 22 papers receiving a total of 804 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Rheumatology, 7 papers in Hematology and 6 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Eva Salgado's work include Rheumatoid Arthritis Research and Therapies (16 papers), Systemic Lupus Erythematosus Research (8 papers) and Monoclonal and Polyclonal Antibodies Research (6 papers). Eva Salgado is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (16 papers), Systemic Lupus Erythematosus Research (8 papers) and Monoclonal and Polyclonal Antibodies Research (6 papers). Eva Salgado collaborates with scholars based in Spain and Japan. Eva Salgado's co-authors include Juan J. Gómez‐Reino, José Ramón Maneiro, Loreto Carmona, Alejandro Souto, Antonio Mera, Maira Bes‐Rastrollo, Jokin de Irala, Eva Pérez‐Pampín, Esperanza Naredo and Montserrat Romera Baurés and has published in prestigious journals such as Annals of the Rheumatic Diseases, Medicine and JAMA Internal Medicine.

In The Last Decade

Eva Salgado

22 papers receiving 786 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eva Salgado Spain 12 506 260 141 104 101 22 804
José Ramón Maneiro Spain 15 741 1.5× 347 1.3× 233 1.7× 166 1.6× 126 1.2× 28 1.1k
Maria Gabriella Raimondo Germany 13 413 0.8× 196 0.8× 154 1.1× 68 0.7× 61 0.6× 33 745
Z. Bahloul Tunisia 16 455 0.9× 256 1.0× 104 0.7× 50 0.5× 60 0.6× 140 905
Álvaro Danza Uruguay 10 553 1.1× 282 1.1× 85 0.6× 32 0.3× 128 1.3× 35 763
Abby Van Voorhees United States 10 478 0.9× 612 2.4× 87 0.6× 31 0.3× 123 1.2× 25 943
M. P. M. van der Linden Netherlands 13 1.1k 2.1× 174 0.7× 277 2.0× 122 1.2× 209 2.1× 16 1.3k
Kumi Shidara Japan 16 430 0.8× 86 0.3× 126 0.9× 99 1.0× 41 0.4× 30 586
Henrique Ataíde Mariz Brazil 11 365 0.7× 247 0.9× 59 0.4× 40 0.4× 139 1.4× 17 695
S. Marzouk Tunisia 14 327 0.6× 255 1.0× 61 0.4× 41 0.4× 64 0.6× 94 652
Tetsuzo Sugisaki Japan 16 177 0.3× 213 0.8× 90 0.6× 59 0.6× 123 1.2× 56 977

Countries citing papers authored by Eva Salgado

Since Specialization
Citations

This map shows the geographic impact of Eva Salgado's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Salgado with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Salgado more than expected).

Fields of papers citing papers by Eva Salgado

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eva Salgado. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Salgado. The network helps show where Eva Salgado may publish in the future.

Co-authorship network of co-authors of Eva Salgado

This figure shows the co-authorship network connecting the top 25 collaborators of Eva Salgado. A scholar is included among the top collaborators of Eva Salgado based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eva Salgado. Eva Salgado is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Salgado, Eva, Montserrat Romera Baurés, E. Beltrán, et al.. (2021). Inmune-mediated inflammatory rheumatic diseases in transgender people: A scoping review. Seminars in Arthritis and Rheumatism. 52. 151920–151920. 10 indexed citations
2.
Salgado, Eva, et al.. (2018). Spanish transcultural adaptation and validation of the English version of the compliance questionnaire in rheumatology. Rheumatology International. 38(3). 467–472. 7 indexed citations
3.
Salgado, Eva, Maira Bes‐Rastrollo, Jokin de Irala, Loreto Carmona, & Juan J. Gómez‐Reino. (2015). High Sodium Intake Is Associated With Self-Reported Rheumatoid Arthritis. Medicine. 94(37). e0924–e0924. 64 indexed citations
4.
Maneiro, José Ramón, Alejandro Souto, Eva Salgado, Antonio Mera, & Juan J. Gómez‐Reino. (2015). Predictors of response to TNF antagonists in patients with ankylosing spondylitis and psoriatic arthritis: systematic review and meta-analysis. RMD Open. 1(1). e000017–e000017. 82 indexed citations
5.
Salgado, Eva & José Ramón Maneiro. (2014). Nuevos tratamientos en artritis reumatoide. Medicina Clínica. 143(10). 461–466. 9 indexed citations
6.
Salgado, Eva, José Ramón Maneiro, & Juan J. Gómez‐Reino. (2014). Predictors of Response to TNF Antagonists. Current Pharmaceutical Design. 21(2). 221–232. 4 indexed citations
7.
Souto, Alejandro, José Ramón Maneiro, Eva Salgado, Loreto Carmona, & Juan J. Gómez‐Reino. (2014). Risk of tuberculosis in patients with chronic immune-mediated inflammatory diseases treated with biologics and tofacitinib: a systematic review and meta-analysis of randomized controlled trials and long-term extension studies. Lara D. Veeken. 53(10). 1872–1885. 102 indexed citations
8.
Souto, Alejandro, Eva Salgado, José Ramón Maneiro, et al.. (2014). Lipid Profile Changes in Patients With Chronic Inflammatory Arthritis Treated With Biologic Agents and Tofacitinib in Randomized Clinical Trials: A Systematic Review and Meta‐Analysis. Arthritis & Rheumatology. 67(1). 117–127. 128 indexed citations
9.
Maneiro, José Ramón, Eva Pérez‐Pampín, Eva Salgado, Loreto Carmona, & Juan J. Gómez‐Reino. (2013). Observational study of optimization of biologic therapies in rheumatoid arthritis: a single-centre experience. Rheumatology International. 34(8). 1059–1063. 16 indexed citations
10.
Maneiro, José Ramón, Eva Salgado, Loreto Carmona, & Juan J. Gómez‐Reino. (2013). Rheumatoid factor as predictor of response to abatacept, rituximab and tocilizumab in rheumatoid arthritis: Systematic review and meta-analysis. Seminars in Arthritis and Rheumatism. 43(1). 9–17. 72 indexed citations
11.
Salgado, Eva, José Ramón Maneiro, Loreto Carmona, & Juan J. Gómez‐Reino. (2013). Safety profile of protein kinase inhibitors in rheumatoid arthritis: systematic review and meta-analysis. Annals of the Rheumatic Diseases. 73(5). 871–882. 52 indexed citations
12.
Maneiro, José Ramón, Eva Salgado, & Juan J. Gómez‐Reino. (2013). Immunogenicity of Monoclonal Antibodies Against Tumor Necrosis Factor Used in Chronic Immune-Mediated Inflammatory Conditions. JAMA Internal Medicine. 173(15). 1416–1416. 117 indexed citations
13.
Salgado, Eva, José Ramón Maneiro, Loreto Carmona, & Juan J. Gómez‐Reino. (2013). Rheumatoid factor and response to TNF antagonists in rheumatoid arthritis: Systematic review and meta-analysis of observational studies. Joint Bone Spine. 81(1). 41–50. 23 indexed citations
14.
Maneiro, José Ramón, et al.. (2013). Maintenance therapy of lupus nephritis with mycophenolate or azathioprine: systematic review and meta-analysis. Lara D. Veeken. 53(5). 834–838. 24 indexed citations
15.
Salgado, Eva & Juan J. Gómez‐Reino. (2013). The JAK inhibitor tofacitinib for active rheumatoid arthritis: results from Phase III trials. International Journal of Clinical Rheumatology. 8(3). 315–326. 2 indexed citations
16.
Maneiro, José Ramón, Eva Salgado, Juan J. Gómez‐Reino, & Loreto Carmona. (2012). Efficacy and Safety of TNF Antagonists in Sarcoidosis: Data from the Spanish Registry of Biologics BIOBADASER and a Systematic Review. Seminars in Arthritis and Rheumatism. 42(1). 89–103. 48 indexed citations
17.
Salgado, Eva, José Ramón Maneiro, Loreto Carmona, & Juan J. Gómez‐Reino. (2012). THU0097 Systematic review of the safety of protein kinase inhibitors in clinical trials in rheumatoid arthritis. Annals of the Rheumatic Diseases. 71. 186–187. 4 indexed citations
18.
Salgado, Eva, José Ramón Maneiro, Loreto Carmona, & Juan J. Gómez‐Reino. (2012). AB0279 Rheumatoid factor and response to TNF antagonists in rheumatoid arthritis: Systematic review and meta-analysis of observational studies. Annals of the Rheumatic Diseases. 71. 653–653. 1 indexed citations
19.
Maneiro, José Ramón, Eva Salgado, Loreto Carmona, & Juan J. Gómez‐Reino. (2012). FRI0079 Rheumatoid factor as predictor of response to non TNF antagonist biologic therapies in rheumatoid arthritis: Systematic review and meta-analysis. Annals of the Rheumatic Diseases. 71. 336–336. 2 indexed citations
20.
Salgado, Eva & Juan J. Gómez‐Reino. (2011). The risk of tuberculosis in patients treated with TNF antagonists. Expert Review of Clinical Immunology. 7(3). 329–340. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026